Zoetis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. 

CEO
Kristin C. Peck
CEOKristin C. Peck
Employees
13,800
Employees13,800
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
1952
Founded1952
Employees
13,800
Employees13,800

ZTS Key Statistics

Market cap
55.89B
Market cap55.89B
Price-Earnings ratio
21.17
Price-Earnings ratio21.17
Dividend yield
1.59%
Dividend yield1.59%
Average volume
3.85M
Average volume3.85M
High today
$128.34
High today$128.34
Low today
$124.55
Low today$124.55
Open price
$124.84
Open price$124.84
Volume
4.12M
Volume4.12M
52 Week high
$177.40
52 Week high$177.40
52 Week low
$115.25
52 Week low$115.25

Stock Snapshot

As of today, Zoetis(ZTS) shares are valued at $126.80. The company's market cap stands at 55.89B, with a P/E ratio of 21.17 and a dividend yield of 1.6%.

During the trading session on 2026-01-09, Zoetis(ZTS) shares reached a daily high of $128.34 and a low of $124.55. At a current price of $126.80, the stock is +1.8% higher than the low and still -1.2% under the high.

Trading volume for Zoetis(ZTS) stock has reached 4.12M, versus its average volume of 3.85M.

Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $177.40 and a low of $115.25.

Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $177.40 and a low of $115.25.

ZTS News

Simply Wall St 13h
What Zoetis's AI Infectious Disease Diagnostics Push Means For Shareholders

In recent days, Zoetis has been cited as a key player in veterinary infectious disease diagnostics, as rising zoonotic diseases and the use of artificial intell...

What Zoetis's AI Infectious Disease Diagnostics Push Means For Shareholders
Simply Wall St 4d
Is Zoetis Now Priced For Opportunity After Recent Share Price Weakness

This article examines whether Zoetis is now priced for opportunity or still appears expensive after a difficult period, walking through what the numbers indicat...

Is Zoetis Now Priced For Opportunity After Recent Share Price Weakness

Analyst ratings

68%

of 22 ratings
Buy
68.2%
Hold
31.8%
Sell
0%

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.